Primecap Management Company Lowered Amgen (AMGN) Position; Shorts at Lgl Group (the) (NYSEAMERICAN:LGL) Raised By 31.03%

May 26, 2018 - By Adrian Erickson

Amgen Inc. (NASDAQ:AMGN) Logo

Primecap Management Company decreased Amgen Inc. (AMGN) stake by 1.03% reported in 2017Q4 SEC filing. Primecap Management Company sold 229,109 shares as Amgen Inc. (AMGN)’s stock declined 2.99%. The Primecap Management Company holds 22.03M shares with $3.83B value, down from 22.26 million last quarter. Amgen Inc. now has $118.71 billion valuation. The stock increased 0.16% or $0.28 during the last trading session, reaching $178.24. About 1.55M shares traded. Amgen Inc. (NASDAQ:AMGN) has risen 3.78% since May 26, 2017 and is uptrending. It has underperformed by 7.77% the S&P500.

Lgl Group Inc (the) (NYSEAMERICAN:LGL) had an increase of 31.03% in short interest. LGL’s SI was 3,800 shares in May as released by FINRA. Its up 31.03% from 2,900 shares previously. With 3,500 avg volume, 1 days are for Lgl Group Inc (the) (NYSEAMERICAN:LGL)’s short sellers to cover LGL’s short positions. The SI to Lgl Group Inc (the)’s float is 0.25%. The stock decreased 2.02% or $0.11 during the last trading session, reaching $5.33. About 6,340 shares traded or 18.75% up from the average. The LGL Group, Inc. (NYSEAMERICAN:LGL) has risen 14.63% since May 26, 2017 and is uptrending. It has outperformed by 3.08% the S&P500.

The LGL Group, Inc., together with its subsidiaries, engages in the design, manufacture, and marketing of standard and custom-engineered electronic components in the United States and internationally. The company has market cap of $25.04 million. The firm operates in two divisions, Electronic Components and Electronic Instruments. It currently has negative earnings. The Electronic Components segment offers packaged quartz crystals, oscillator modules, electronic filters, and integrated modules that are used primarily to control the frequency or timing of signals in electronic circuits.

Investors sentiment increased to 9 in Q4 2017. Its up 8.75, from 0.25 in 2017Q3. It is positive, as 1 investors sold The LGL Group, Inc. shares while 0 reduced holdings. 2 funds opened positions while 7 raised stakes. 1.86 million shares or 361.04% more from 404,140 shares in 2017Q3 were reported. Gamco Et Al reported 0.02% stake. Vanguard Gp holds 0% or 63,393 shares. Blackrock Inc holds 0% or 449 shares. Moreover, Morgan Stanley has 0% invested in The LGL Group, Inc. (NYSEAMERICAN:LGL) for 480 shares. Deutsche Savings Bank Ag reported 0% of its portfolio in The LGL Group, Inc. (NYSEAMERICAN:LGL). Minerva Advsr Limited Liability invested 0.15% of its portfolio in The LGL Group, Inc. (NYSEAMERICAN:LGL). 3,802 were reported by Acadian Asset Ltd Llc. Renaissance Techs Limited Liability Corporation invested in 131,700 shares or 0% of the stock. Dimensional Fund Advsr Limited Partnership invested in 119,600 shares.

Among 25 analysts covering Amgen Inc. (NASDAQ:AMGN), 11 have Buy rating, 0 Sell and 14 Hold. Therefore 44% are positive. Amgen Inc. had 89 analyst reports since August 3, 2015 according to SRatingsIntel. Mizuho maintained Amgen Inc. (NASDAQ:AMGN) on Monday, February 12 with “Buy” rating. The stock has “Buy” rating by Jefferies on Thursday, September 28. BMO Capital Markets maintained Amgen Inc. (NASDAQ:AMGN) on Friday, October 20 with “Hold” rating. On Friday, July 14 the stock rating was maintained by Mizuho with “Buy”. The stock has “Overweight” rating by Morgan Stanley on Thursday, October 26. The firm earned “Buy” rating on Tuesday, July 11 by Jefferies. The stock of Amgen Inc. (NASDAQ:AMGN) earned “Hold” rating by RBC Capital Markets on Thursday, October 26. The company was initiated on Thursday, February 25 by Citigroup. On Monday, June 19 the stock rating was maintained by Oppenheimer with “Buy”. RBC Capital Markets maintained it with “Outperform” rating and $190 target in Friday, July 31 report.

More notable recent Amgen Inc. (NASDAQ:AMGN) news were published by: 247Wallst.com which released: “Amgen Wins Another FDA Approval” on May 22, 2018, also 247Wallst.com with their article: “Amgen’s Novel Migraine Treatment Gets Key Approval” published on May 18, 2018, Nasdaq.com published: “3 Big Pharma Stocks with Huge Future Growth Potential” on May 24, 2018. More interesting news about Amgen Inc. (NASDAQ:AMGN) were released by: 247Wallst.com and their article: “Short Interest Remains Mixed in Major Biotechs” published on May 25, 2018 as well as Streetinsider.com‘s news article titled: “Amgen (AMGN), NCI Enter Pact to Improve Symptom Management During Cancer” with publication date: May 24, 2018.

Primecap Management Company increased Jpmorgan Chase & Co. (NYSE:JPM) stake by 12,917 shares to 23.36 million valued at $2.50B in 2017Q4. It also upped Textron Inc. (NYSE:TXT) stake by 466,284 shares and now owns 4.03 million shares. Cbs Corporation (NYSE:CBS) was raised too.

Investors sentiment increased to 1.22 in 2017 Q4. Its up 0.23, from 0.99 in 2017Q3. It increased, as 73 investors sold AMGN shares while 458 reduced holdings. 122 funds opened positions while 527 raised stakes. 551.71 million shares or 0.60% less from 555.05 million shares in 2017Q3 were reported. 10 holds 0.84% or 20,276 shares in its portfolio. State Farm Mutual Automobile Insur invested in 0.71% or 3.26 million shares. Community Trust And Investment Commerce reported 1,590 shares. Pinnacle Advisory Group has invested 0.04% in Amgen Inc. (NASDAQ:AMGN). Grand Jean Capital Mgmt Incorporated holds 0.14% or 2,453 shares. Inv Prtnrs Ltd Oh Adv reported 3,750 shares. Argent Tru reported 3,038 shares or 0.14% of all its holdings. 131,385 are owned by Personal Cap. Grimes & Com stated it has 0.91% in Amgen Inc. (NASDAQ:AMGN). Campbell Newman Asset Mgmt Inc accumulated 59,572 shares or 1.75% of the stock. The Massachusetts-based Boston Advsrs Llc has invested 0.87% in Amgen Inc. (NASDAQ:AMGN). 265,097 are owned by Silvercrest Asset Management Ltd Liability. Mengis Cap invested in 8,125 shares. Gilman Hill Asset Management Ltd holds 0.29% or 4,072 shares. The Massachusetts-based St Germain D J has invested 2.03% in Amgen Inc. (NASDAQ:AMGN).

Since December 12, 2017, it had 0 buys, and 6 sales for $1.64 million activity. Another trade for 1,525 shares valued at $265,625 was made by Harper Sean E on Wednesday, February 14.

Analysts await Amgen Inc. (NASDAQ:AMGN) to report earnings on July, 24. They expect $3.52 EPS, up 7.65% or $0.25 from last year’s $3.27 per share. AMGN’s profit will be $2.34B for 12.66 P/E if the $3.52 EPS becomes a reality. After $3.47 actual EPS reported by Amgen Inc. for the previous quarter, Wall Street now forecasts 1.44% EPS growth.

Amgen Inc. (NASDAQ:AMGN) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts